GlassScriptPhysician profile
Lauren E Seiter
NPI 1548817661
$360.70
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $361.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $49.75 | 2022 | |
| Sunovion Pharmaceuticals INC. | $43.24 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $38.95 | 2022 | |
| Alkermes, INC. | $37.05 | 2022 | |
| Abbvie INC. | $35.42 | 2022 | |
| Corium, LLC | $30.30 | 2022 | |
| Bausch Health US, LLC | $23.28 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $22.50 | 2022 | |
| Lundbeck LLC | $18.81 | 2022 | |
| Neurocrine Biosciences, INC. | $17.39 | 2022 | |
| Vanda Pharmaceuticals INC. | $16.68 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.87 | 2022 | |
| Neuronetics, INC. | $12.46 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Seiter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.